2.16.840.1.113883.5.1070/static-2012-07-24: Unterschied zwischen den Versionen

Aus Hl7wiki
Wechseln zu: Navigation, Suche
(Automated TermBot page content)
(Automated TermBot page content)
Zeile 9: Zeile 9:
 
| colspan=2 bgcolor="#F6F3EE"|''substanceAdminSubstitution''
 
| colspan=2 bgcolor="#F6F3EE"|''substanceAdminSubstitution''
 
| bgcolor="#F6F3EE"|2.16.840.1.113883.5.1070
 
| bgcolor="#F6F3EE"|2.16.840.1.113883.5.1070
−
| bgcolor="#F6F3EE"|2012-07-24T00:00:00
+
| bgcolor="#F6F3EE"|2012-07-24
 
| bgcolor="#F6F3EE"|definitiv
 
| bgcolor="#F6F3EE"|definitiv
 
|-
 
|-
Zeile 17: Zeile 17:
 
| bgcolor="#ECE9E4" colspan="2"|'''Beschreibung'''
 
| bgcolor="#ECE9E4" colspan="2"|'''Beschreibung'''
 
|-
 
|-
 +
|-
 +
|0-A
 +
|_ActSubstanceAdminSubstitutionCode
 +
|<font color="grey">(en-US)</font> ActSubstanceAdminSubstitutionCode
 +
| colspan="2" |<p>Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.</p>
 +
|-
 +
|1-S
 +
|'''E'''
 +
|<font color="grey">(en-US)</font> equivalent
 +
| colspan="2" |<p>Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.</p>
 +
|-
 +
|2-S
 +
|'''EC'''
 +
|<font color="grey">(en-US)</font> equivalent composition
 +
| colspan="2" |<p>Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril</p>
 +
|-
 +
|3-L
 +
|'''BC'''
 +
|<font color="grey">(en-US)</font> brand composition
 +
| colspan="2" |<p>Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven</p>
 +
|-
 +
|3-L
 +
|'''G'''
 +
|<font color="grey">(en-US)</font> generic composition
 +
| colspan="2" |<p>Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)</p>
 +
|-
 +
|2-S
 +
|'''TE'''
 +
|<font color="grey">(en-US)</font> therapeutic alternative
 +
| colspan="2" |<p>Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet</p>
 +
|-
 +
|3-L
 +
|'''TB'''
 +
|<font color="grey">(en-US)</font> therapeutic brand
 +
| colspan="2" |<p>Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics> Examples: Zantac for Tagamet</p>
 +
|-
 +
|3-L
 +
|'''TG'''
 +
|<font color="grey">(en-US)</font> therapeutic generic
 +
| colspan="2" |<p>Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands> Examples: Ranitidine for cimetidine</p>
 +
|-
 +
|1-L
 +
|'''F'''
 +
|<font color="grey">(en-US)</font> formulary
 +
| colspan="2" |<p>Description: This substitution was performed or is permitted based on formulary guidelines.</p>
 +
|-
 +
|1-L
 +
|'''N'''
 +
|<font color="grey">(en-US)</font> none
 +
| colspan="2" |<p>No substitution occurred or is permitted.</p>
 
|}
 
|}

Version vom 11. November 2012, 18:48 Uhr

Codesystem Name Codesystem Id Version / Eingangsdatum Status
substanceAdminSubstitution 2.16.840.1.113883.5.1070 2012-07-24 definitiv
Level/Typ Code Anzeigename Beschreibung
0-A _ActSubstanceAdminSubstitutionCode (en-US) ActSubstanceAdminSubstitutionCode

Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

1-S E (en-US) equivalent

Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

2-S EC (en-US) equivalent composition

Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril

3-L BC (en-US) brand composition

Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven

3-L G (en-US) generic composition

Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)

2-S TE (en-US) therapeutic alternative

Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet

3-L TB (en-US) therapeutic brand

Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics> Examples: Zantac for Tagamet

3-L TG (en-US) therapeutic generic

Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands> Examples: Ranitidine for cimetidine

1-L F (en-US) formulary

Description: This substitution was performed or is permitted based on formulary guidelines.

1-L N (en-US) none

No substitution occurred or is permitted.

Abgerufen von „https://wiki.hl7.de/index.php?title=2.16.840.1.113883.5.1070/static-2012-07-24&oldid=8858“